J Korean Soc Radiol.
2020 May;81(3):753-753. 10.3348/jksr.2020.81.3.753.
Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
- Affiliations
-
- 1Departments of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
- 2Departments of Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
- 3Departments of Pathology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
- KMID: 2502373
- DOI: http://doi.org/10.3348/jksr.2020.81.3.753
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
- Bilateral Triple-Negative Invasive Breast Cancer with a BRCA2 Mutation, and Glioblastoma: A Case Report and Literature Review
- Pathologic Findings of Residual Tumor according to the Response Rate after Neoadjuvant Chemotherapy for Breast Cancer
- PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
- Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancerâ€
